​
​

Plus Therapeutics Ownership | Who Owns Plus Therapeutics?

OverviewRevenueFinancialsChartTranscripts

Plus Therapeutics Ownership Summary

Plus Therapeutics is owned by 0.39% institutional investors, and 99.61% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.61% of its assets in Plus Therapeutics shares.

PSTV Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockPlus Therapeutics0.39%-99.61%
SectorHealthcare Stocks 47.25%8.01%44.75%
IndustryBiotech Stocks 45.35%7.81%46.83%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Extended Market Index36.27K0.61%3.92K
Vanguard Institutional Extnd Mkt Idx Tr32.54K0.55%-
Fidelity Nasdaq Composite Index8.90K0.15%-
Fidelity Series Total Market Index8.28K0.14%4.32K
Northern Trust Extended Eq Market Idx2.33K0.04%-
NT Ext Equity Mkt Idx Fd - L2.33K0.04%-
NT Ext Equity Mkt Idx Fd - NL1.44K0.02%-
NT Ext Equity Mkt Idx Fd - DC - NL - T21.16K0.02%4.00
Spartan Total Market Index Pool E700.000.01%-
State St US Extended Mkt Indx NL Cl C663.000.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 13, 2024Hawkins Richard J-Buy$6.00K
Sep 12, 2024Hawkins Richard J-Buy$8.51K
Sep 11, 2024Petersen Greg-Buy$16.88K
Sep 11, 2024Clowes Howard-Buy$6.68K
Sep 10, 2024HEDRICK MARC H Chief Executive OfficerBuy$9.84K

Insider Transactions Trends

DateBuySell
2024 Q34-
2024 Q26-
2024 Q1--
2023 Q481
2023 Q32-

PSTV Ownership FAQ

Who Owns Plus Therapeutics?

Plus Therapeutics shareholders are primarily institutional investors at 0.39%, followed by 0% insiders and 0% retail investors. The average institutional ownership in Plus Therapeutics's industry, Biotech Stocks , is 45.35%, which Plus Therapeutics falls below.

Does Blackrock own Plus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Plus Therapeutics.

Who is the top mutual fund holder of Plus Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Plus Therapeutics shares, with 0.61% of its total shares outstanding invested in 36.26K Plus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools